The withdrawn drug Ramonovan demonstrated efficacy in weight loss and improved metabolic markers in diabetic patients.

“large randomized trials with ramona man have demonstrated efficacy and treatment of overweight and obese individuals with weight loss significantly greater than a reduced calorie diet alone in addition multiple other cardio metabolic parameters were improved in treatment groups including increased d increased levels of high density lipoprotein reduced triglycerides reduced weight circumference improved insulin sensitivity decreased insulin levels and in diabetic patients improvement in hba1c”